These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11673481)

  • 1. Cutting edge: membrane lymphotoxin regulates CD8(+) T cell-mediated intestinal allograft rejection.
    Guo Z; Wang J; Meng L; Wu Q; Kim O; Hart J; He G; Zhou P; Thistlethwaite JR; Alegre ML; Fu YX; Newell KA
    J Immunol; 2001 Nov; 167(9):4796-800. PubMed ID: 11673481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutting edge: blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells.
    Newell KA; He G; Guo Z; Kim O; Szot GL; Rulifson I; Zhou P; Hart J; Thistlethwaite JR; Bluestone JA
    J Immunol; 1999 Sep; 163(5):2358-62. PubMed ID: 10452966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts.
    Williams MA; Trambley J; Ha J; Adams AB; Durham MM; Rees P; Cowan SR; Pearson TC; Larsen CP
    J Immunol; 2000 Dec; 165(12):6849-57. PubMed ID: 11120808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice.
    Gao D; Li J; Orosz CG; Bumgardner GL
    Hepatology; 2000 Nov; 32(5):1018-28. PubMed ID: 11050052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of 4-1BB in allograft rejection mediated by CD8+ T cells.
    Wang J; Guo Z; Dong Y; Kim O; Hart J; Adams A; Larsen CP; Mittler RS; Newell KA
    Am J Transplant; 2003 May; 3(5):543-51. PubMed ID: 12752310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts.
    Jones TR; Ha J; Williams MA; Adams AB; Durham MM; Rees PA; Cowan SR; Pearson TC; Larsen CP
    J Immunol; 2002 Feb; 168(3):1123-30. PubMed ID: 11801646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different costimulatory and growth factor requirements for CD4+ and CD8+ T cell-mediated rejection.
    Vu MD; Amanullah F; Li Y; Demirci G; Sayegh MH; Li XC
    J Immunol; 2004 Jul; 173(1):214-21. PubMed ID: 15210777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.
    Lin H; Rathmell JC; Gray GS; Thompson CB; Leiden JM; Alegre ML
    J Exp Med; 1998 Jul; 188(1):199-204. PubMed ID: 9653096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors.
    Li W; Lu L; Wang Z; Wang L; Fung JJ; Thomson AW; Qian S
    Transplantation; 2001 Oct; 72(8):1423-32. PubMed ID: 11685115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role of OX40 in CD28 and CD154-independent rejection.
    Demirci G; Amanullah F; Kewalaramani R; Yagita H; Strom TB; Sayegh MH; Li XC
    J Immunol; 2004 Feb; 172(3):1691-8. PubMed ID: 14734751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
    Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML
    J Immunol; 2000 Nov; 165(10):5580-7. PubMed ID: 11067913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
    Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL
    J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An antagonist IL-15/Fc protein prevents costimulation blockade-resistant rejection.
    Ferrari-Lacraz S; Zheng XX; Kim YS; Li Y; Maslinski W; Li XC; Strom TB
    J Immunol; 2001 Sep; 167(6):3478-85. PubMed ID: 11544341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD28-independent costimulation of T cells in alloimmune responses.
    Yamada A; Kishimoto K; Dong VM; Sho M; Salama AD; Anosova NG; Benichou G; Mandelbrot DA; Sharpe AH; Turka LA; Auchincloss H; Sayegh MH
    J Immunol; 2001 Jul; 167(1):140-6. PubMed ID: 11418642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody.
    Sun H; Subbotin V; Chen C; Aitouche A; Valdivia LA; Sayegh MH; Linsley PS; Fung JJ; Starzl TE; Rao AS
    Transplantation; 1997 Dec; 64(12):1838-43. PubMed ID: 9422428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of CD28/B7 blockade on alloreactive T and B cells after liver cell transplantation.
    Reddy B; Gupta S; Chuzhin Y; Kalergis AM; Budhai L; Zhang M; Droguett G; Horwitz MS; Chowdhury JR; Nathenson SG; Davidson A
    Transplantation; 2001 Mar; 71(6):801-11. PubMed ID: 11330546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4.
    Mandelbrot DA; Oosterwegel MA; Shimizu K; Yamada A; Freeman GJ; Mitchell RN; Sayegh MH; Sharpe AH
    J Clin Invest; 2001 Apr; 107(7):881-7. PubMed ID: 11285307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis.
    Kim KS; Denton MD; Chandraker A; Knoflach A; Milord R; Waaga AM; Turka LA; Russell ME; Peach R; Sayegh MH
    Am J Pathol; 2001 Mar; 158(3):977-86. PubMed ID: 11238045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4.
    Markees TG; Phillips NE; Gordon EJ; Noelle RJ; Shultz LD; Mordes JP; Greiner DL; Rossini AA
    J Clin Invest; 1998 Jun; 101(11):2446-55. PubMed ID: 9616216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8 T cell-mediated rejection of intestinal allografts is resistant to inhibition of the CD40/CD154 costimulatory pathway.
    Guo Z; Meng L; Kim O; Wang J; Hart J; He G; Alegre ML; Thistlethwaite JR; Pearson TC; Larsen CP; Newell KA
    Transplantation; 2001 May; 71(9):1351-4. PubMed ID: 11403253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.